The kinetics of Ras activation by Son of sevenless (SOS) changes profoundly when Ras is tethered to membranes, instead of being in solution. SOS has two binding sites for Ras, one of which is an allosteric site that is distal to the active site. The activity of the SOS catalytic unit (SOS cat ) is up to 500-fold higher when Ras is on membranes compared to rates in solution, because the allosteric Ras site anchors SOS cat to the membrane. This effect is blocked by the N-terminal segment of SOS, which occludes the allosteric site. We show that SOS responds to the membrane density of Ras molecules, to their state of GTP loading and to the membrane concentration of phosphatidylinositol-4,5-bisphosphate (PIP 2 ), and that the integration of these signals potentiates the release of autoinhibition.
replacement of Arg552 by glycine, resulting in enhanced activation of Ras and extracellular signal-regulated kinase 2 (ERK) after epidermal growth factor (EGF) stimulation 26, 27 . Other mutations associated with Noonan syndrome map to the regions of SOS that interact with the allosteric Ras molecule or are predicted to help destabilize the autoinhibited conformation.
Membrane-bound Ras could, in principle, maintain SOS at the membrane by engaging the allosteric site. Such colocalization could increase the ability of SOS to catalyze nucleotide exchange on Ras dramatically, by increasing the probability of encounters between SOS and Ras, and potentially short-circuit the controls that make SOS sensitive to input signals. To address this issue, we studied the kinetics of human Ras activation by SOS when Ras is tethered to membranes. Simply constraining the physical dimensionality of the reaction to a surface by coupling Ras (but not SOS) to phospholipid membranes leads to a dramatic increase (up to B500-fold) in the activity of SOS cat . This effect requires Ras binding to the allosteric site of SOS, and is further enhanced by the conversion of Ras-GDP to Ras-GTP. The unchecked activation of Ras is prevented by the N-terminal domains of SOS, which block the localization of SOS to the membrane by allosteric Ras. A key insight is provided by investigation of the Noonan syndrome-associated mutation R552G, which is found to activate SOS only in a membrane context and only in the presence of PIP 2 . The activity of autoinhibited SOS is stimulated by increasing Ras density at the membrane, by the replacement of Ras-bound GDP by GTP and by increasing PIP 2 concentrations in the membrane. Our results suggest that full activation of SOS requires the integration of multiple membrane-dependent signals, as well as further anchorage of SOS to the membrane, such as by the coupling to activated receptors.
RESULTS

Covalent attachment of Ras to membrane surfaces
We attached the conserved core of Ras to lipid membranes covalently using thiol-maleimide crosslinking 28 . This strategy avoids the difficulties inherent in purifying lipid-modified Ras. A previous report has suggested that the lipid modification of Ras can alter its behavior as a substrate for SOS 29 , but these studies were done with both Ras and SOS in solution and its relevance to the interaction of SOS with membrane-bound Ras is unclear.
We quantified SOS activity by monitoring the displacement of fluorescently labeled GDP analogs bound to Ras by excess unlabeled GDP or GTP 8, [30] [31] [32] . To ensure that our results were robust, we tethered Ras to both small unilamellar lipid vesicles (average diameter B100 nm) and planar supported lipid bilayers 33 . Direct observation of fluorescently labeled nucleotides bound to Ras molecules coupled to the surface of supported lipid bilayers verified that the membrane components were fluid and homogenously mixed and that aggregation was not a factor. The vesicle system, on the other hand, allows a more rapid bulk experimental readout. By using both methods, we explored a greater range of Ras-SOS concentrations than would be possible with either one alone, and we have unified our results with a single quantitative kinetic model. Different fluorescent nucleotides were used in the two experimental configurations (Methods). Ras surface densities for lipid vesicles are in the range of B800 to B17,000 molecules per mm 2 (Supplementary Table 1 online and Methods). For the supported bilayers, the Ras surface densities range from B500 to B4,500 Ras molecules per mm 2 (Methods).
The number of Ras molecules on the surface of an NIH3T3 cell is estimated to be in the range of 10,000-50,000 (ref. 34) . Assuming a diameter of 10 mm and a spherical shape, this corresponds to a surface density of uniformly distributed Ras in the range of 30-150 Ras molecules per mm 2 . H-Ras and K-Ras are not uniformly distributed, but instead form dynamically exchanging nanoclusters, with about 30% of the Ras molecules in these nanoclusters 35, 36 . The radius of a nanocluster is estimated to be 6-12 nm, with a surface density of B4,000 to B16,000 Ras molecules per mm 2 . Thus, our experimental Ras surface densities are in the range of densities within these nanoclusters, the formation of which is essential for Ras activation 35, 36 . For comparison, the maximal close-packed density of Ras molecules on a surface is estimated to be B100,000 molecules per mm 2 .
Enhanced activity of SOS cat when Ras is on membranes
We compared the SOS cat -catalyzed nucleotide exchange rate in solution to the rate obtained for a reaction at the same overall Ras and SOS concentrations by volume, except that all the Ras molecules were tethered to lipid vesicles. For consistency with previous solution studies 10,37 , we kept the bulk concentrations of both Ras and SOS at 1 mM and exchanged mant-dGDP 31 for unlabeled GDP. In both cases, overall nucleotide exchange rates showed pseudo-first-order kinetics, because the fluorescently labeled nucleotide that is detected was replaced by unlabeled nucleotide. The exchange rate is 0.0019 ± 0.0001 s -1 with both SOS cat and Ras in solution, whereas a nearly 500-fold increase to 0.84 ± 0.06 s -1 is measured for membranetethered Ras (surface density B5,300 molecules per mm 2 ; Fig. 2 ).
To ensure that membrane anchorage of Ras did not alter the intrinsic rate of nucleotide release, we took advantage of an isolated Cdc25 domain construct of the SOS homolog Ras guanine nucleotide-releasing factor 1 (RasGRF1). In contrast to SOS, which is active only when Ras binds to the allosteric site that bridges the REM and Cdc25 domains, the isolated Cdc25 domain of RasGRF1 is active on its own 9, 37 . The rate of RasGRF1-catalyzed nucleotide release was 0.0071 ± 0.0001 s -1 with both RasGRF1 and Ras in solution, and no considerable difference was observed when Ras was membrane-bound (the release rate is 0.0086 ± 0.0002 s -1 for a Ras surface density of B2,600 molecules per mm 2 on vesicles; Supplementary Fig. 1 online) .
Dependence of Ras activation on membrane surface density The pronounced acceleration in the rate of SOS cat -catalyzed nucleotide exchange upon restricting Ras to membranes suggested that the allosteric Ras binding site might be localizing SOS to the membrane, where the probability of encounters with substrate Ras molecules is increased greatly. In support of this hypothesis, the observed SOS cat -catalyzed nucleotide release rate increased as a function of Ras surface density on the membrane for both lipid vesicles and planar lipid bilayers (Fig. 3 shows data for GDP replacing Ras-bound nucleotide). This dependency on Ras surface density is robust and is quantitatively predicted by the following reaction model over a wide range of experimental parameters:
Here, Ras * and Ras 0 refer to Ras bound to labeled and unlabeled nucleotide, respectively (see Supplementary Discussion online for a complete description of the reaction scheme). RasÁSOS, SOSÁRas and RasÁSOSÁRas represent Ras bound at the allosteric site, the catalytic site and at both sites, respectively. All Ras molecules are attached to the membrane, and all SOS molecules are either in solution or bound to one or two Ras molecules. The model does not include any direct interaction between SOS and the membrane and considers only GDP replacing Ras-bound nucleotide.
The predicted values of the overall exchange rates for this simplified reaction scheme are superimposed onto the experimental data presented in Figure 3 . As expected, much of the rate acceleration is predicted to arise from the ability of the allosteric Ras binding site to recruit and localize SOS cat to the membrane. Binding of Ras at the allosteric site converts SOS cat from an inactive conformation to an active one, but these observations of kinetic rate enhancements as a function of Ras surface density indicate that membrane recruitment has a major role in addition to any such direct allostery.
For the supported bilayers, only a small amount of Ras is present, because the membrane is restricted to a single surface of the reaction chamber. A low concentration of SOS (10 nM) was therefore used in these experiments. Even so, SOS in the reaction chamber is in excess and its concentration in solution remains essentially constant throughout the reaction. The vesicle experiments were done with both high (1 mM) and low (10 nM) SOS concentrations, but in both cases SOS was limiting and the concentration of free SOS in solution decreased as the reaction proceeds. Nonetheless, the reaction scheme depicted above accurately predicts all of the data from both systems on the basis of a single set of kinetic parameters. © 2008 Nature Publishing Group http://www.nature.com/nsmb Figure 3 The membrane-dependent increase in the rate of SOS cat -catalyzed Ras exchange is a function of the surface density of Ras. (a) The rate for SOS cat -catalyzed nucleotide exchange for Ras coupled to lipid vesicles is shown as a function of Ras surface density (Ras per mm 2 ). Although the surface density of Ras is varied, the bulk volume concentrations of SOS and Ras are the same for each measurement (1 mM). MantdGDP is displaced by unlabeled GDP. Experimental rates are shown as points. The solid line represents the rates predicted from the kinetic scheme (Supplementary Discussion).
(b) The rate for SOS cat -catalyzed nucleotide exchange for Ras coupled to supported lipid bilayers is shown as a function of Ras surface density. In these experiments there is a large excess of SOS molecules versus membranebound Ras ([SOS] ¼ 10 nM). BODIPY-GDP is used as the fluorescent nucleotide. Experimental data are indicated by points, and the solid line represents the rates predicted by the kinetic model, using the same set of parameters as in a. Two data points, between densities of 3,000-4,000 Ras per mm 2 , have apparently aberrant values, but are included for completeness. (Fig. 4a) . In contrast, a SOS cat variant containing two mutations that weaken the binding of Ras to the allosteric site (SOS cat(L687E R688A) ) 10,11 fails to localize to the membrane (Fig. 4a ). These results demonstrate that the interaction of Ras with the allosteric site is necessary to promote the stable interaction of SOS cat with the plasma membrane.
To assess the functional significance of this recruitment mechanism we measured the signaling output of SOS cat using ERK-MAP kinase activation as a readout. As seen previously, expression of SOS cat in cells leads to robust activation of ERK2 (ref. 10) . A mutant of SOS cat in which interaction with Ras at the allosteric site is weakened, SOS cat(L687E R688A) , is defective in ERK2 kinase activation 10 (Fig. 4b) . This defect is fully rescued by constitutive membrane targeting of SOS cat(L687E R688A) using a Ras-derived membrane-anchoring sequence (Fig. 4b) . Because Ras binding at the allosteric site is required for SOS activity 9 , we infer that the strong interaction between the membrane and lipid-modified SOS, which increases the local concentration of SOS at the membrane, drives the binding of Ras to the allosteric site despite the impedance arising from mutations at the allosteric site.
Role of the allosteric site in SOS activation at the membrane The cell-based studies described above show that mutations at the allosteric site prevent the membrane localization of SOS cat . Such mutations should also prevent the membrane-dependent enhancement of SOS cat activity in vitro. Indeed, membrane-dependent stimulation of the nucleotide exchange rate is substantially reduced in a SOS cat variant that has reduced affinity for allosteric Ras (SOS cat(W729E) ). This mutant form of SOS has essentially the same properties as SOS cat(L687E R688A) , used in the cell-based experiments 10 , and the in vitro data for SOS cat(W729E) are discussed later. Interpretation of the reduced activity of SOS cat(W729E) in terms of membrane localization is, however, complicated by the fact that Ras binding to the allosteric site is required for SOS activation even when Ras is in solution 10 . We therefore carried out additional experiments that test the importance of the allosteric site in membrane anchorage, using SOS cat with an intact allosteric site. These experiments rely on a Ras mutant (Ras Y64A ) that binds to only the allosteric site 8, 10 .
Ras-GTP binds about tenfold more tightly to the allosteric site than does Ras-GDP 10 . When all reaction components are in solution, the addition of Ras Y64A bound to the nonhydrolyzable GTP analog GppNp (Ras Y64A -GppNp) stimulates the activity of SOS cat (refs. 8,10) . The nucleotide exchange rate increases from 0.0019 ± 0.0001 s -1 (without Ras Y64A -GppNp) to 0.085 ± 0.002 s -1 (tenfold excess of Ras Y64A -GppNp; 1 mM Ras-GDP and SOS cat , GDP exchanged for GDP; Fig. 5a ). The results are different when the substrate Ras-GDP molecules are tethered to lipid vesicles and the allosteric activator Ras Y64A -GppNp is added in solution. Instead of increasing, the exchange rate decreases slightly, from 0.15 ± 0.01 s -1 (for a moderate Ras surface density of 1,300 Ras per mm 2 and a bulk concentration of Ras and SOS cat of 1 mM) to 0.062 ± 0.007 s -1 for the same reaction carried out in the presence of a tenfold excess of Ras Y64A -GppNp in solution (Fig. 5b) . We interpret this to mean that addition of Ras Y64A -GppNp in solution competes with membrane-bound Ras for the allosteric site of SOS cat , thereby trapping some of the SOS cat in solution. These exchange reactions were carried out with excess unlabeled GDP. When excess unlabeled GTP is used instead, the Ras-GTP produced by the exchange reaction is attached to the membrane, and this results in an Btenfold increase in the rate of SOS cat -catalyzed nucleotide release for an equal surface density of membrane-bound Ras ( Supplementary Fig. 2 online) .
In another experiment, we coupled the allosteric activator Ras Y64A -GppNp to lipid vesicles but kept substrate Ras-GDP in solution. For comparison, when Ras Y64A -GppNp, Ras-GDP (substrate Ras) and SOS cat are all in solution, the rate of SOS cat -catalyzed nucleotide release from Ras is 0.027 ± 0.001 s -1 (1:1:1 stoichiometric ratio of Ras-GDP: SOS cat : Ras Y64A -GppNp, all at 1 mM concentration). In contrast, when Ras Y64A -GppNp is membrane-tethered, and Ras-GDP and SOS cat are both in solution, the rate decreases to 0.0110 ± 0.0009 s -1 (all components at 1 mM bulk concentration; Fig. 5c is defective in ERK-MAP kinase activation, but targeting SOS cat(L687E R688A) to the membrane using the Ras-derived membrane anchoring sequence, CAAX, fully restores SOS signaling activity. Error bars in the bar graph represent the s.d. from three independent experiments. The levels of ERK activation, as represented by ERK phosphorylation (P-ERK; green (appears yellow due to overlap)), were quantified by densitometry and normalized to levels of total ERK (ERK; red). P-ERK and ERK comigrate, so the appearance of P-ERK gives an apparently yellow color. a.u., arbitrary units; WCL, whole cell lysate. interpret this result to mean that SOS cat is trapped by membranebound Ras Y64A and is less accessible to Ras-GDP in solution.
The N-terminal regulatory segment inhibits SOS The ability of membrane-tethered Ras to stimulate the activity of SOS cat raises the question of how the activity of SOS is suppressed until an activating signal is received. Insight is provided by analysis of SOS constructs that contain the N-terminal domains in addition to SOS cat (SOS DPC and SOS HDPC ; Fig. 1a ). For an equal surface density of membrane-bound Ras, the rate of nucleotide release for SOS DPC and SOS HDPC is between 10 times and 60 times slower than for SOS cat (reactions carried out with a 1:1 stoichiometric ratio of SOS and membrane-coupled Ras-GDP, at a bulk concentration of 1 mM; Figs. 3a and 6a). We conclude that an important role of the histone domain and the DH-PH unit of SOS is to inhibit the localization of SOS to the membrane by allosteric Ras.
The inhibitory effect of the DH-PH unit was also manifested when fluorescently labeled GDP bound to Ras was replaced with GTP, despite the enhanced affinity of Ras-GTP for the allosteric site 8, 10 ( Supplementary Fig. 2 ). For example, Figure 6b compares the activities of SOS DPC , SOS HDPC and SOS cat toward membrane-bound Ras when labeled GDP is exchanged for either unlabeled GDP or unlabeled GTP (bulk concentration of Ras and SOS is 1 mM). The reactions are compared for the same level of Ras surface density (B1,300 Ras molecules per mm 2 ), and the replacement of GDP by GTP results in a marked increase in the reaction rate of all SOS constructs (Fig. 6b) . Nevertheless, in comparison to SOS cat , the presence of the DH-PH unit in SOS DPC and SOS HDPC suppresses the exchange activity substantially (Fig. 6b) .
PIP 2 -dependent activation of SOS
The crystal structure of a construct of SOS containing intact regulatory and catalytic segments (SOS HDPC ) has been determined recently and indicates that the histone domain interacts with the DH domain, the PH domain and the helical PH-REM linker (Olga K. and J.K., unpublished data). A modeled location of the histone domain, which is based on small-angle X-ray scattering data 24 and is correct in general terms although not in detail, is shown in Figure 1b Error bars indicate the means with standard error from at least two independent experiments. (b) The activities of SOS DPC (gray), SOS HDPC (purple) and SOS cat (green) toward Ras coupled to vesicles when mantdGDP is exchanged for either unlabeled GDP or unlabeled GTP are compared for an equal surface density of Ras (B1,300 Ras per mm 2 ; bulk concentration of Ras and SOS is 1 mM). Note that the replacement of GDP for GTP on membrane-bound Ras results in a strong enhancement in the activity of all SOS constructs.
SOS 24 and leads to increased Ras activation 26, 27 , suggesting that the docking of the histone domain is crucial for inhibition. We therefore wondered whether the ability of the R552G mutation to activate SOS is due to release of the blockage of the allosteric site by the N-terminal segment.
We first compared the properties of three SOS constructs, two with the histone domain (SOS HDPC and SOS HDPC(R552G) ) and one without (SOS DPC ), in experiments where both Ras and SOS are present in solution, at 1 mM concentration. All three SOS constructs show low levels of activity compared to SOS cat , even when the reaction is carried out in an excess of unlabeled GTP (Fig. 7a) . These results demonstrate that the Noonan syndrome-associated mutation has no noticeable effect on SOS activity when Ras and SOS are both off the membrane.
Next we compared the same three SOS constructs, but this time with Ras localized to lipid vesicles. We used a bulk SOS concentration of 10 nM, which is 100-fold lower than that used in the first set of experiments and resulted in SOS cat activity that was roughly the same as the solution rate (compare Fig. 7a,b) . Again, SOS HDPC , SOS HDPC(R552G) and SOS DPC showed low levels of activity, essentially indistinguishable from background (Fig. 7b) . Thus, the Noonan syndrome-associated mutation in SOS does not allow Ras to access the allosteric site on these membranes, which contain phosphatidylcholine (PC) and phosphatidylserine (PS) (see Methods for a detailed description of the membrane composition).
The PH domain of SOS binds to PIP 2 in vesicles with relatively high affinity (K d E1 mM) [14] [15] [16] [17] (also see Supplementary Fig. 3 online) . In addition, a role for phosphatidic acid in activating SOS has been reported recently 18, 38 . We therefore wondered whether lipid binding to the PH domain of SOS could potentiate the effect of the R552G mutation. Figure 7b shows the results of experiments where Ras is coupled to lipid vesicles and mant-dGDP is displaced by unlabeled GTP in the presence of 10 nM SOS DPC , SOS HDPC and SOS HDPC(R552G) . Inclusion of PIP 2 in membranes results in a marked increase in the activity of SOS constructs containing the Noonan syndromeassociated mutation (SOS HDPC(R552G) ) or in which the histone domain is entirely deleted (SOS DPC ) (Fig. 7b) . For example, the rate of nucleotide release by SOS HDPC(R552G) is 0.0126 ± 0.0007 s -1 , compared to 0.019 ± 0.003 s -1 for SOS DPC , both in the presence of 3% PIP 2 . The rate for SOS HDPC is 0.0010 ± 0.0001 s -1 , that is, the same as that for the unstimulated reaction (Fig. 7b) . Similar results are obtained using supported bilayers instead of vesicles, as shown in Figure 7c The PIP 2 -dependent activity of SOS DPC is abolished if the PH domain of SOS is mutated so that it cannot bind to PIP 2 (SOS DPC(K456E R459E) ) ( Fig. 7b and Supplementary Fig. 3) . Thus, the effect of PIP 2 is mediated through the PH domain. The simplest explanation for the ability of PIP 2 to stimulate SOS activity is that it engages the PH domain and thereby provides an additional tether for SOS at the membrane. The resulting enhancement in the local concentration of SOS would facilitate entry of Ras to the allosteric site, overcoming the resistance afforded by the N-terminal segment. Notably, the inclusion of phosphatidic acid in membranes, either alone or with PIP 2 , has no effect on the rates of nucleotide exchange in our assays for the constructs tested (data not shown). Another interesting point is the mechanism by which the histone domain impedes the activity of SOS HDPC . SOS HDPC binds to PIP 2 -containing vesicles ( Supplementary Fig. 3) , suggesting that the histone domain does not directly occlude the PH domain but might instead block the simultaneous engagement of the membrane by the PH domain and the two Ras binding sites of SOS.
Integration of membrane-dependent signals by SOS
In the preceding sections, the activities of different SOS constructs were compared under similar conditions, emphasizing the inhibitory action of the N-terminal segment. A different perspective emerges, however, when the activity of any one particular construct of SOS is monitored as the reaction conditions are changed.
Our results show that increasing the surface density of Ras on membranes results in substantial increases in SOS activity. Although the highest levels of activity were seen with SOS cat , all the constructs of SOS that we studied responded in a similar way to Ras surface density (Figs. 3a and 6a) . Even for SOS HDPC , which had the lowest activity in our assays, the rate of nucleotide release increased by about 65-fold as the Ras surface density increased from 830 Ras per mm 2 to 8,200 Ras per mm 2 for reactions in which labeled GDP is replaced by unlabeled GDP (bulk concentration of Ras and SOS is 1 mM) (Fig. 6a) . Superimposed on this Ras density dependence is the effect of Ras-GTP production, which increased the activity of SOS cat , SOS DPC and SOS HDPC by roughly another factor of ten, for the same surface density of Ras (Fig. 6b and Supplementary Fig. 2) . It was shown recently that the activation of Ras is coupled to the formation of nanoclusters that are crucial for a switch-like response to the input signal 35 . The local concentration of Ras within these nanoclusters is likely to be about two orders of magnitude greater than if Ras were distributed uniformly throughout the plasma membrane, as noted earlier. Thus, the dependence of SOS activity on both Ras surface density and the state of GTP loading on Ras could provide one mechanism for making Ras activation contingent on the formation of Ras nanoclusters.
PIP 2 is present in biological membranes at levels of 1-5% total lipid 39 . The level of PIP 2 is elevated in HeLa cells following EGF stimulation and is responsive to the activation of phospholipase D and the production of phosphatidic acid 40 . SOS is responsive to the membrane density of PIP 2 . For example, Figure 8 compares the activity of the Noonan syndrome-associated mutant (SOS HDPC(R552G) , 10 nM bulk concentration) when Ras was tethered to membranes containing 1% and 3% PIP 2 . Reactions using vesicles with a higher PIP 2 density showed higher levels of SOS activity (0.0117 s -1 versus 0.0028 s -1 ), even though the Ras surface density was lower for the vesicles with higher PIP 2 (B4,800 moelcules per mm 2 versus 6,000 molecules per mm 2 ). Our procedure for cross-linking Ras to vesicles did not allow us to precisely control the Ras surface densities, which were determined only after the vesicles were prepared. A more thorough mapping of the responsiveness of SOS to the surface densities of Ras and PIP 2 awaits further study.
DISCUSSION
The classical model for the activation of Ras by SOS involves the partitioning of SOS from the cytoplasm to the plasma membrane in response to growth factor-induced receptor activation. Such a mechanism leaves open the possibility that chance encounters between SOS and Ras would lead to the erroneous activation of Ras, with disastrous consequences for the cell. We had shown previously that Figure 9 The integration of several membrane-localization signals in the activation of Ras and SOS. (a) At low Ras-GDP (orange) surface densities and low surface concentrations of PIP 2 (purple circles), the N-terminal regulatory segment maintains SOS in an inactive state by inhibiting the localization of SOS to the membrane by allosteric Ras. Ras binding to the allosteric site causes a conformational change at the active site, promoting substrate engagement 9 . (b) The activity of autoinhibited SOS is stimulated by increasing Ras density at the membrane, the replacement of Ras-bound GDP by GTP (green) and by increasing PIP 2 concentrations in the membrane. (c) Further anchorage of SOS to the membrane, such as by the coupling to activated receptors, in combination with high levels of Ras density, the generation of Ras-GTP and high levels of PIP 2 , results in effective release of autoinhibition.
SOS is inactive unless Ras is bound to the allosteric site, and that the enhanced affinity of Ras-GTP for this site makes SOS sensitive to the activation state of Ras. We now demonstrate that Ras is able to localize the SOS catalytic unit to the membrane and strongly potentiate its activity. The N-terminal segment of SOS blocks the engagement of the allosteric site by Ras, providing a thermodynamic resistance to direct activation of SOS by Ras. But, because Ras is at the membrane, this mechanism also enables the activation of SOS in response to several cues that can act synergistically to overcome this resistance (Fig. 9) . A key finding in this regard is that a Noonan syndrome-associated mutation in SOS (R552G), which weakens the autoinhibition of SOS, results in activation only in a membrane-dependent context. The presence of the allosteric Ras binding site makes all the SOS constructs that we have studied, even those that are autoinhibited, responsive to the surface density of Ras. The increased density of Ras in nanoclusters 35 is therefore expected to strongly enhance SOS activity. The generation of an initial burst of Ras-GTP, either through the coupling of SOS to activated receptors, or through the action of agents such as phosphatidic acid 18 or a priming exchange factor such as Ras-GRP1 12 , will also result in substantial stimulation of SOS activity. SOS is responsive to the surface concentration of PIP 2 , and we have shown that the combination of high Ras surface density, the presence of Ras-GTP and high levels of PIP 2 results in increased SOS activity despite the presence of the autoinhibitory segments.
SOS seems to have evolved the capability of integrating several signals as a condition for the activation of Ras signaling. This property of SOS is reminiscent of the membrane-dependent activation of the Wiscott-Aldrich syndrome protein (WASP), which is controlled by Rho GTPases and other signals, such as the membrane density of PIP 2 , that are integrated to result in activation 41, 42 . This complexity in the input-output response functions of proteins that are at key nodes in cellular signal transduction is likely to emerge as a general theme that ensures fidelity in cellular responses to input signals.
METHODS
Protein preparation. SOS HDPC (residues 1-1049), SOS DPC (residues 198-1049) and SOS cat (residues 566-1049) of human SOS1 were expressed and purified as described 10, 24 . We generated point mutants using the Quikchange site-directed mutagenesis kit (Stratagene) and confirmed by DNA sequencing. Mutant proteins were expressed and purified as for the wild-type proteins.
The typical 166-residue H-Ras construct used in previous studies 8, 10 was extended to include a C-terminal cysteine at position 181. Cys118 of human Ha-Ras was mutated to serine, leaving one cysteine at position 181. Ras (C181,C118S) (residues 1-181, C118S) was cloned into a pProEx HTb vector (Invitrogen) using a BamHI and a EcoRI site. Ras (C181,C118S) was produced in Escherichia coli and purified using an N-terminal hexahistidine tag. Following elution, buffers were exchanged using a Fast Desalting Column (GE Healthcare) equilibrated in 25 mM Tris-Cl (pH 8.2), 50 mM NaCl and 4 mM DTT, followed by either size-exclusion chromatography on a Superdex 75 column (GE Healthcare) that was equilibrated in gel-filtration buffer (25 mM HEPESNaOH (pH 7.4), 100 mM NaCl, 10% (w/v) glycerol and 2 mM Tris (2-carboxyethyl) phosphine (TCEP)) or treated with the tobacco etch virus (TEV) protease overnight at 4 1C before gel-filtration chromatography. Fractions of Ras (C181,C118S) were pooled and frozen at a final concentration of about 10 mg ml -1 . MS analysis confirmed the identity of the proteins. Lipids. The fluorescent lipid analogs Texas Red 1,2-dihexadecanoylsn-glycero-3-phosphoethanolamine (TR-DHPE) and Marina Blue 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (MB-DHPE) were purchased from Invitrogen.
Maleimide-functionalized vesicles were prepared by drying a mixture of DOPC, DOPS, MCC-PE and TR-DHPE (vesicle experiments) or MB-DHPE (supported bilayer experiments) in chloroform. Mixtures contained 10 mol% (molar percentage) DOPS, 0-10 mol% MCC-PE, 0.3 mol% TR-DHPE or 2 mol% MB-DHPE, and the balance consisted of DOPC. Some experiments also included DOPA, PIP 2 or PIP 3 where noted. Dried lipid films were placed under vacuum or a gentle nitrogen stream for at least 1 h and resuspended in degassed buffer (25mM HEPES-NaOH (pH 7.4), 100 mM NaCl and 10% (w/v) glycerol). The hydrated films were subjected to repeated freeze-thaw cycles, and vesicles formed by extrusion through 100 nm polycarbonate filters or by probe sonication for PIP 2 -containing supported bilayer experiments. Vesicles were then immediately conjugated to Ras (C181,C118S) (overnight, 4 1C), or used to form supported bilayers by vesicle rupture followed by Ras (C181,C118S) linkage (overnight, 4 1C).
Preparation of Ras-coupled lipid vesicles. Ras (C181,C118S) was coupled to vesicles containing between 1-10 mol% maleimide-derivatized lipid in a reaction carried out under argon for 2 h at room temperature. Maleimidelipid was present in ten-fold molar excess over Ras (C181,C118S) . Coupling reactions were terminated and excess maleimide-lipid quenched by addition of 5 mM b-mercaptoethanol. Unmodified Ras (C181,C118S) protein was separated from Ras (C181,C118S) -conjugated vesicles by size-exclusion chromatography using an XK-16 column (GE Healthcare) containing about 30 ml of Sepharose CL-4B resin (Sigma) equilibrated in gel-filtration buffer (25 mM HEPESNaOH (pH 7.4), 100 mM NaCl, 10% (w/v) glycerol and 1 mM DTT). Vesicle diameter (100-140 nm) and monodispersity both before and after Ras conjugation was confirmed by dynamic light scattering (Wyatt DynaPro Titan). MS confirmed the formation of a stable thioether linkage between Ras (C181,C118S) and maleimide-derivatized lipids.
The lipid concentration after Ras (C181,C118S) conjugation was determined by TR-DHPE absorbance. Protein concentration and conjugation efficiency was measured by Bradford assay of Ras (C181,C118S) -containing vesicles, where the Bradford reagent signal due to lipids was removed by assaying equivalent vesicle solutions with no protein. We used SDS-PAGE to confirm protein conjugation measurements by creating solutions of equal Ras concentration by volume, but with different Ras conjugation efficiencies.
Nucleotide exchange experiments using Ras-coupled lipid vesicles. Nucleotide exchange activity was measured as described 8, 10 . We used mant-dGDP (Jena Biosciences) instead of mant-GDP to avoid artifacts caused by isomerization of the fluorescent label 31 . Ras-coupled vesicles were incubated with a ten-fold molar excess of mant-dGDP in the presence of 0.2 mM EDTA in gelfiltration buffer. Reactions were stopped with 4 mM MgCl 2 , and free nucleotide was removed by gel filtration using Nap-10 columns (GE Healthcare) equilibrated with reaction buffer (40 mM HEPES-NaOH (pH 7.4), 4 mM MgCl 2 and 1 mM DTT). The final concentration of Ras-mant-dGDP-coupled vesicles was obtained using the Texas Red dilution factor, as described above.
Reactions were initiated by rapid mixing of 100 ml of 2 mM (or 20 nM) SOS with 100 ml of Ras-mant-dGDP-conjugated vesicles using a stopped-flow apparatus (RX2000; Applied Photophysics) linked to a Fluoromax-3 fluorimeter (HORIBA Jobin Yvon). The surface density of Ras was varied, but the total concentration of Ras stock before mixing was kept constant at 2 mM. Reaction progress was monitored by fluorescence intensity at 430 nm with 370 nm excitation. Reactions were performed at 25 1C in reaction buffer supplemented with 2 mM unlabeled GDP or GTP nucleotide.
Data were obtained by repeating reactions on different days with different protein samples and different Ras-coupled vesicle preparations. The data were fit to either a single-or double-exponential decay function using the program Prism 4 (Graphpad Prism, Inc.). For display purposes, data were normalized between 1 and the minimum fluorescence value observed for a given preparation of vesicles.
Preparation of Ras-conjugated supported planar bilayers. Supported bilayer experiments were performed in a glass-bottomed 96-well plate (Nalge Nunc International). Maleimide-functionalized vesicles (50 ml, 1 mg ml -1 total lipid concentration) in 50 mM Tris-HCl (pH 7.4) and 750 mM NaCl were added to 50 ml H 2 O in a NaOH-cleaned well, equilibrated for 10 min, and rinsed with 5 mL 0.1% (w/v) BSA in 10 mM Tris-HCl (pH 7.4) and 150 mM NaCl. Ras (C181,C118S) protein was added to a final concentration of 8 mg ml -1 and the conjugation was carried out overnight at 4 1C. Bilayers were washed with 5 mL loading buffer (40 mM HEPES-NaOH (pH 7.4)) supplemented with 50 mM EDTA followed by incubation for 1.5 h at 4 1C.
Wells were re-equilibrated into loading buffer and incubated with 100 mM BODIPY-GDP or BODIPY-GTP (Invitrogen) with 5 mM MgCl 2 for 1 h at 4 1C. Unbound nucleotide was washed away with loading buffer supplemented with 5 mM MgCl 2 . Fluorescence recovery showed that both MB-DHPE lipids and BODIPY-labeled nucleotides on Ras were laterally mobile ( Supplementary  Fig. 4 online) .
The surface density of Ras in each well was measured after exchange reactions were complete by mouse anti-pan-Ras IgG (EMD Biosciences) binding followed by BODIPY goat-anti-mouse IgG (Invitrogen) binding. The fluorescence intensity of anti-mouse IgG (adjusted for labeling efficiency and absorption-fluorescence characteristics) was compared to bilayer standards with known BODIPY-DHPE lipid density. 
